3rd Health Working Group Meeting at Hyderabad

Tags: National Summits National News

3rd-Health-Working-Group-Meeting-at-HyderabadThe third meeting of the G20 Health Working Group (HWG) was held at Hyderabad from June 4 to 6.

An overview of the news

  • Union Minister of State for Health and Family Welfare Dr. Bharti Praveen Pawar addressed the 3rd Health Working Group meeting under the G20 India Presidency.

  • The 3rd meeting of the HWG held a main event focusing on cooperation in R&D of Medical Counter Measures (MCMs).

Highlights of the event

Co-branded events

  • The meeting included co-branded events with the Global Vaccine Research Collaborative and the Joint Finance Health Task Force meeting.

  • The objective of these events is to increase cooperation in the field of healthcare.


  • The meeting was attended by representatives of 19 G20 member states, 10 invited countries and 22 international organizations.

Proposed deliverables

  • The HWG has proposed a number of deliverables, including a mapping of ongoing initiatives in health emergencies, prevention, preparedness and response.

  • The launch of a Climate Change and Health Centre, regional networks for vaccines, therapeutics and diagnostics (VTD) research and development, and the creation of a global medical countermeasure coordination platform were also discussed.

Global Initiative on Digital Health

  • Another proposed 'Global Initiative on Digital Health' was launched.

  • The initiative aims to establish an institutional framework for convergence of existing digital health initiatives.

Past HWG Meetings

  • Health priorities were introduced and discussed in detail during the HWG meetings held in Thiruvananthapuram and Goa earlier this year, emphasizing the importance of advancing health objectives.

Showcasing India's Life Sciences and Pharmaceutical Manufacturing

  • Delegates will have the opportunity to visit 'Genome Valley' in Hyderabad, a well-known hub for global life science companies.

  • The visit will highlight India's expertise in life science research and drug manufacturing.

  • Genome Valley is responsible for 33% of global vaccine production, including vaccines for diseases such as COVID-19, polio and rotavirus.

Please Rate this article, so that we can improve the quality for you -